OmpA and Asp14 in vaccine compositions and as diagnostic targets
US-10039815-B2 · Aug 7, 2018 · US
Immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis
US11459379B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11459379-B2 |
| Application number | US-202016809105-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2020 |
| Priority date | Jun 16, 2005 |
| Publication date | Oct 4, 2022 |
| Grant date | Oct 4, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of inducing an immune response in a mammalian subject, comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a glycosylated recombinant polypeptide comprising SEQ ID NO:22 or SEQ ID NO:23 and a pharmaceutically acceptable excipient. 2. The method of claim 1 , wherein the recombinant polypeptide is less than 250 amino acids in length. 3. The method of claim 1 , wherein the recombinant polypeptide is less than 220 amino acids in length. 4. The method of claim 1 , wherein the recombinant polypeptide is less than 200 amino acids in length. 5. The method of claim 1 , wherein the recombinant polypeptide is less than 150 amino acids in length. 6. The method of claim 1 , wherein the subject is a human. 7. A method of inducing an immune response in a mammalian subject, comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a glycosylated recombinant polypeptide comprising SEQ ID NO:45 or SEQ ID NO:46 and a pharmaceutically acceptable excipient. 8. The method of claim 7 , wherein the recombinant polypeptide is less than 250 amino acids in length. 9. The method of claim 7 , wherein the recombinant polypeptide is less than 220 amino acids in length. 10. The method of claim 7 , wherein the recombinant polypeptide is less than 200 amino acids in length. 11. The method of claim 7 , wherein the recombinant polypeptide is less than 150 amino acids in length. 12. The method of claim 7 , wherein the subject is a human.
Assignees
Inventors
Classifications
Detection of antigens from microorganism in sample from host · CPC title
- C07K16/1246Primary
Rickettsiales (O) · CPC title
Bacteria · CPC title
from bacteria · CPC title
from Richettsiales (O) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11459379B2 cover?
- The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
- Who is the assignee on this patent?
- Res Found Dev
- What technology area does this patent fall under?
- Primary CPC classification C07K16/1246. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).